
Tanya B Dorff MD
Associate Clinical Professor; Head, GU Cancer Program, City of Hope, Duarte, CaliforniaRecent Contributions to PracticeUpdate:
- Defining Value in Metastatic Prostate Cancer
- Sequencing Atezolizumab and Sipuleucel-T for Castration-Resistant Prostate Cancer
- Bone Supportive Therapy and Radium-223 for Metastatic Prostate Cancer
- Chemotherapy for Oligometastatic Prostate Cancer
- Androgen Deprivation Therapy Plus Enzalutamide for Hormone-Sensitive Prostate Cancer
- Ipilimumab Plus Nivolumab for mCRPC
- Evidence-Based Chemotherapy for Oligometastatic Prostate Cancer
- Contemporary Management of Penile Cancer
- Potential Role for High Dose IL-2 in mRCC: New Data From ASCO GU 2018
- New Insights on Immune-Related Adverse Events in GU Cancers From ASCO GU 2018